Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
102.5 GBX | -2.38% | -10.87% | -10.87% |
Business Summary
Number of employees: 24
Managers
Managers | Title | Age | Since |
---|---|---|---|
James Short
FOU | Founder | 55 | 17-12-31 |
Jonathan Turner
DFI | Director of Finance/CFO | 46 | 23-01-16 |
Iqbal Gill
CTO | Chief Tech/Sci/R&D Officer | - | - |
Arthur Wakeley
PRN | Corporate Officer/Principal | - | - |
Burleigh Abbott
PRN | Corporate Officer/Principal | - | - |
Kerin Williams
SEC | Corporate Secretary | 46 | - |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
David Firth
BRD | Director/Board Member | 62 | - |
Ian Anton
CHM | Chairman | 64 | 22-03-27 |
Robert Barr
BRD | Director/Board Member | 65 | 22-03-27 |
Steven Hajioff
BRD | Director/Board Member | 58 | 22-03-27 |
Jonathan Turner
DFI | Director of Finance/CFO | 46 | 23-01-16 |
James Short
FOU | Founder | 55 | 17-12-31 |
Director/Board Member | 59 | - |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 64,208,903 | 21,738,143 ( 33.86 %) | 0 | 33.86 % |
Company contact information
Sector
1st Jan change | Capi. | |
---|---|---|
-10.87% | 81.98M | |
+25.83% | 661B | |
+27.00% | 566B | |
-6.76% | 352B | |
+20.34% | 332B | |
+3.00% | 283B | |
+13.09% | 231B | |
+5.46% | 200B | |
-9.61% | 195B | |
-6.26% | 145B |
- Stock Market
- Equities
- CEL Stock
- Company Celadon Pharmaceuticals Plc